Global L-Carnosine API 麻豆原创 Growth 2025-2031

Publication ID:

LPI08254235

Publication Date:

August 6, 2025

Pages:

104

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Food Processing [2]

Food [3]

Food & Beverages [4]

Description:

The global L-Carnosine API market size is predicted to grow from US$ 29.0 million in 2025 to US$ 37.5 million in 2031; it is expected to grow at a CAGR of 4.4% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
L-carnosine, also simply known as carnosine, is a dipeptide molecule that consists of two amino acids (beta alanine and histidine) and is found primarily in muscle and brain tissue. L-carnosine is found in highest concentrations in meats. L-Carnosine is an antioxidant amino acid that helps to fight against free radicals.L-carnosine has anti-aging properties, can be taken for depression, heart health, autism, diabetes and more. The L-Carnosine market covers Purity 鈮�98% and Purity 鈮�99%. The typical players include Fushilai Pharmaceutical, Hamari Chemicals, Wuhan BJM Pharm Inc., Hubei Huntide Biotech Co., Ltd, Jiangsu Chengxin Pharmaceutical Co., Ltd, Belle Chemical, KS-V Peptide, Bachem, etc.
The global L-Carnosine API market is poised for continued growth, driven by its wide range of applications in anti-aging skincare, dietary supplements, pharmaceuticals, and sports nutrition. As consumer awareness of its health benefits increases and new product innovations emerge, L-Carnosine is expected to gain further traction in both established and emerging markets. The trend toward health-conscious living, coupled with advancements in product formulation and research, will further shape the future of the L-Carnosine market.
Global core l-carnosine API manufacturers include Fushilai Pharmaceutical, Hamari Chemicals etc. The Top 2 companies hold a share above 65%. Asia Pacific is the largest market, with a share about 60%, followed by Europe and North America with the share about 20% and 15%. In terms of product, purity 鈮�99% is the largest segment, with a share over 95%. And in terms of application, the largest application is dietary supplements, followed by pharmaceutical.
The 鈥淟-Carnosine API Industry Forecast鈥� looks at past sales and reviews total world L-Carnosine API sales in 2024, providing a comprehensive analysis by region and market sector of projected L-Carnosine API sales for 2025 through 2031. With L-Carnosine API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world L-Carnosine API industry.
This Insight Report provides a comprehensive analysis of the global L-Carnosine API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on L-Carnosine API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global L-Carnosine API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for L-Carnosine API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global L-Carnosine API.
This report presents a comprehensive overview, market shares, and growth opportunities of L-Carnosine API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity 鈮�98%
Purity 鈮�99%
Segmentation by Application:
Dietary Supplements
Pharmaceutical
Cosmetics and Personal Care
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Fushilai Pharmaceutical
Hamari Chemicals
Wuhan BJM Pharm Inc.
Hubei Huntide Biotech Co.,Ltd
Jiangsu Chengxin Pharmaceutical Co., Ltd
Belle Chemical
KS-V Peptide
Bachem
Suzhou Tianma Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global L-Carnosine API market?
What factors are driving L-Carnosine API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do L-Carnosine API market opportunities vary by end market size?
How does L-Carnosine API break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global L-Carnosine API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for L-Carnosine API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for L-Carnosine API by Country/Region, 2020, 2024 & 2031
2.2 L-Carnosine API Segment by Type
2.2.1 Purity 鈮�98%
2.2.2 Purity 鈮�99%
2.3 L-Carnosine API Sales by Type
2.3.1 Global L-Carnosine API Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global L-Carnosine API Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global L-Carnosine API Sale Price by Type (2020-2025)
2.4 L-Carnosine API Segment by Application
2.4.1 Dietary Supplements
2.4.2 Pharmaceutical
2.4.3 Cosmetics and Personal Care
2.5 L-Carnosine API Sales by Application
2.5.1 Global L-Carnosine API Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global L-Carnosine API Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global L-Carnosine API Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global L-Carnosine API Breakdown Data by Company
3.1.1 Global L-Carnosine API Annual Sales by Company (2020-2025)
3.1.2 Global L-Carnosine API Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global L-Carnosine API Annual Revenue by Company (2020-2025)
3.2.1 Global L-Carnosine API Revenue by Company (2020-2025)
3.2.2 Global L-Carnosine API Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global L-Carnosine API Sale Price by Company
3.4 Key Manufacturers L-Carnosine API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers L-Carnosine API Product Location Distribution
3.4.2 Players L-Carnosine API Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for L-Carnosine API by Geographic Region
4.1 World Historic L-Carnosine API 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global L-Carnosine API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global L-Carnosine API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic L-Carnosine API 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global L-Carnosine API Annual Sales by Country/Region (2020-2025)
4.2.2 Global L-Carnosine API Annual Revenue by Country/Region (2020-2025)
4.3 Americas L-Carnosine API Sales Growth
4.4 APAC L-Carnosine API Sales Growth
4.5 Europe L-Carnosine API Sales Growth
4.6 Middle East & Africa L-Carnosine API Sales Growth
5 Americas
5.1 Americas L-Carnosine API Sales by Country
5.1.1 Americas L-Carnosine API Sales by Country (2020-2025)
5.1.2 Americas L-Carnosine API Revenue by Country (2020-2025)
5.2 Americas L-Carnosine API Sales by Type (2020-2025)
5.3 Americas L-Carnosine API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC L-Carnosine API Sales by Region
6.1.1 APAC L-Carnosine API Sales by Region (2020-2025)
6.1.2 APAC L-Carnosine API Revenue by Region (2020-2025)
6.2 APAC L-Carnosine API Sales by Type (2020-2025)
6.3 APAC L-Carnosine API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe L-Carnosine API by Country
7.1.1 Europe L-Carnosine API Sales by Country (2020-2025)
7.1.2 Europe L-Carnosine API Revenue by Country (2020-2025)
7.2 Europe L-Carnosine API Sales by Type (2020-2025)
7.3 Europe L-Carnosine API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa L-Carnosine API by Country
8.1.1 Middle East & Africa L-Carnosine API Sales by Country (2020-2025)
8.1.2 Middle East & Africa L-Carnosine API Revenue by Country (2020-2025)
8.2 Middle East & Africa L-Carnosine API Sales by Type (2020-2025)
8.3 Middle East & Africa L-Carnosine API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of L-Carnosine API
10.3 Manufacturing Process Analysis of L-Carnosine API
10.4 Industry Chain Structure of L-Carnosine API
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 L-Carnosine API Distributors
11.3 L-Carnosine API Customer
12 World Forecast Review for L-Carnosine API by Geographic Region
12.1 Global L-Carnosine API 麻豆原创 Size Forecast by Region
12.1.1 Global L-Carnosine API Forecast by Region (2026-2031)
12.1.2 Global L-Carnosine API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global L-Carnosine API Forecast by Type (2026-2031)
12.7 Global L-Carnosine API Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Fushilai Pharmaceutical
13.1.1 Fushilai Pharmaceutical Company Information
13.1.2 Fushilai Pharmaceutical L-Carnosine API Product Portfolios and Specifications
13.1.3 Fushilai Pharmaceutical L-Carnosine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Fushilai Pharmaceutical Main Business Overview
13.1.5 Fushilai Pharmaceutical Latest Developments
13.2 Hamari Chemicals
13.2.1 Hamari Chemicals Company Information
13.2.2 Hamari Chemicals L-Carnosine API Product Portfolios and Specifications
13.2.3 Hamari Chemicals L-Carnosine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Hamari Chemicals Main Business Overview
13.2.5 Hamari Chemicals Latest Developments
13.3 Wuhan BJM Pharm Inc.
13.3.1 Wuhan BJM Pharm Inc. Company Information
13.3.2 Wuhan BJM Pharm Inc. L-Carnosine API Product Portfolios and Specifications
13.3.3 Wuhan BJM Pharm Inc. L-Carnosine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Wuhan BJM Pharm Inc. Main Business Overview
13.3.5 Wuhan BJM Pharm Inc. Latest Developments
13.4 Hubei Huntide Biotech Co.,Ltd
13.4.1 Hubei Huntide Biotech Co.,Ltd Company Information
13.4.2 Hubei Huntide Biotech Co.,Ltd L-Carnosine API Product Portfolios and Specifications
13.4.3 Hubei Huntide Biotech Co.,Ltd L-Carnosine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Hubei Huntide Biotech Co.,Ltd Main Business Overview
13.4.5 Hubei Huntide Biotech Co.,Ltd Latest Developments
13.5 Jiangsu Chengxin Pharmaceutical Co., Ltd
13.5.1 Jiangsu Chengxin Pharmaceutical Co., Ltd Company Information
13.5.2 Jiangsu Chengxin Pharmaceutical Co., Ltd L-Carnosine API Product Portfolios and Specifications
13.5.3 Jiangsu Chengxin Pharmaceutical Co., Ltd L-Carnosine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Jiangsu Chengxin Pharmaceutical Co., Ltd Main Business Overview
13.5.5 Jiangsu Chengxin Pharmaceutical Co., Ltd Latest Developments
13.6 Belle Chemical
13.6.1 Belle Chemical Company Information
13.6.2 Belle Chemical L-Carnosine API Product Portfolios and Specifications
13.6.3 Belle Chemical L-Carnosine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Belle Chemical Main Business Overview
13.6.5 Belle Chemical Latest Developments
13.7 KS-V Peptide
13.7.1 KS-V Peptide Company Information
13.7.2 KS-V Peptide L-Carnosine API Product Portfolios and Specifications
13.7.3 KS-V Peptide L-Carnosine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 KS-V Peptide Main Business Overview
13.7.5 KS-V Peptide Latest Developments
13.8 Bachem
13.8.1 Bachem Company Information
13.8.2 Bachem L-Carnosine API Product Portfolios and Specifications
13.8.3 Bachem L-Carnosine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bachem Main Business Overview
13.8.5 Bachem Latest Developments
13.9 Suzhou Tianma Pharmaceutical
13.9.1 Suzhou Tianma Pharmaceutical Company Information
13.9.2 Suzhou Tianma Pharmaceutical L-Carnosine API Product Portfolios and Specifications
13.9.3 Suzhou Tianma Pharmaceutical L-Carnosine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Suzhou Tianma Pharmaceutical Main Business Overview
13.9.5 Suzhou Tianma Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.